Maiva Pharma, a Bengaluru-based injectables manufacturer, has secured ₹1,000 crore in a mix of primary and secondary funding from a fund managed by Morgan Stanley Private Equity Asia and India Life Sciences Fund-IV, led by InvAscent, to set up a new manufacturing plant near Hosur, Tamil Nadu. Maiva already has a plant in Hosur producing sterile injectables in vials and …
